Department of Periodontology, School of Dental Medicine, University of Bern, Bern, Switzerland.
Department of Oral and Maxillofacial Surgery, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark.
Clin Implant Dent Relat Res. 2021 Apr;23(2):189-196. doi: 10.1111/cid.12973. Epub 2021 Jan 15.
Implant-supported restorations with cantilever extension may display high rates of biological and technical complications.
To report the outcomes of single-unit crowns with cantilever extension (SCCs).
Patients with SCCs were reevaluated after ≥10 years of loading. Radiographic marginal bone levels (mBLs) at baseline (ie, delivery of SCCs) and follow-up were calculated and compared between implant surfaces adjacent to and distant from the cantilever extension. Implant survival and success rates were calculated.
Twenty-one patients with 25 SCs supported by 25 implants were reevaluated after a mean of 13.6 ± 3.8 years (range: 10-19 years). No implants were lost. The mean overall mBLs changed from 0.99 mm ± 0.95 at baseline to 0.95 mm ± 0.99 at follow-up (p = 0.853). The mean pocket probing depths changed from 3.39 mm ± 0.62 at baseline to 3.34 mm ± 0.54 at follow-up (p = 0.635). Loss of retention occurred 3× in 2 patients (14.3%). At follow-up, peri-implant health was diagnosed in 10 (48%) and peri-implant mucositis in 11 (52%) patients, respectively.
Within the limitations of the present study, the use of implant-supported SCs with cantilever extension in posterior areas represents a reliable long-term treatment option with a 100% implant survival rate and minimal marginal bone level changes.
带有悬臂延伸的种植体支持修复体可能会出现较高的生物学和技术并发症。
报告带有悬臂延伸的单冠修复体(SCCs)的结果。
对加载后≥10 年的 SCCs 患者进行重新评估。在基线(即 SCCs 交付时)和随访时计算并比较相邻和远离悬臂延伸的种植体表面的放射学边缘骨水平(mBL)。计算种植体存活率和成功率。
21 名患者的 25 个 SCCs 由 25 个种植体支撑,平均随访时间为 13.6±3.8 年(范围:10-19 年)。无种植体丢失。总体 mBL 从基线时的 0.99±0.95mm 增加到随访时的 0.95±0.99mm(p=0.853)。平均探诊深度从基线时的 3.39±0.62mm 增加到随访时的 3.34±0.54mm(p=0.635)。2 名患者(14.3%)发生了 3 次固位丧失。在随访时,分别有 10 名(48%)和 11 名(52%)患者被诊断为种植体周围健康和种植体周围黏膜炎。
在本研究的限制范围内,在后牙区使用带有悬臂延伸的种植体支持的 SCC 是一种可靠的长期治疗选择,具有 100%的种植体存活率和最小的边缘骨水平变化。